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A B S T R A C T
Background: Neuromelanin-pigmented neurons, which are highly susceptible to neurodegeneration in the
Parkinson’s disease substantia nigra, harbour elevated iron levels in the diseased state. Whilst it is widely be-
lieved that neuronal iron is stored in an inert, ferric form, perturbations to normal metal homeostasis could
potentially generate more reactive forms of iron capable of stimulating toxicity and cell death. However, non-
disruptive analysis of brain metals is inherently challenging, since use of stains or chemical fixatives, for ex-
ample, can significantly influence metal ion distributions and/or concentrations in tissues.
Aims: The aim of this study was to apply synchrotron soft x-ray spectromicroscopy to the characterisation of iron
deposits and their local environment within neuromelanin-containing neurons of Parkinson’s disease substantia
nigra.
Methods: Soft x-ray spectromicroscopy was applied in the form of Scanning Transmission X-ray Microscopy
(STXM) to analyse resin-embedded tissue, without requirement for chemically disruptive processing or staining.
Measurements were performed at the oxygen and iron K-edges in order to characterise both organic and in-
organic components of anatomical tissue using a single label-free method.
Results: STXM revealed evidence for mixed oxidation states of neuronal iron deposits associated with neuro-
melanin clusters in Parkinson’s disease substantia nigra. The excellent sensitivity, specificity and spatial re-
solution of these STXM measurements showed that the iron oxidation state varies across sub-micron length
scales.
Conclusions: The label-free STXM approach is highly suited to characterising the distributions of both inorganic
and organic components of anatomical tissue, and provides a proof-of-concept for investigating trace metal
speciation within Parkinson’s disease neuromelanin-containing neurons.
1. Introduction
Many neurodegenerative disorders are associated with altered metal
ion metabolism in the brain [1]. In Parkinson’s disease (PD), iron levels
are significantly elevated in the type of nerve cell most severely com-
promised by disease progression – the dopaminergic neurons within the
substantia nigra pars compacta (SNc) region [2]. Death of these vul-
nerable dopamine-producing neurons ultimately leads to a severe de-
pletion of striatal dopamine, inducing the characteristic symptoms of
PD such as tremor, rigidity and bradykinesia. Although trace metals are
essential for normal physiological brain function, localised
perturbations to metal homeostasis could potentially be responsible for
initiating toxicity and region-specific cell death [3–5]. Thus, it is critical
to develop methods capable of characterising changes in metal chem-
istry at a subcellular level.
The high rate of oxidative metabolism and augmented iron con-
centrations leave the brain particularly susceptible to oxidative stress
[6]. Whilst redox switching between ferric (Fe3+) and ferrous (Fe2+)
forms is key to iron’s functional role in neurotransmitter synthesis,
myelin synthesis and cellular metabolism [3], these reactions can also
generate reactive oxygen species which are highly toxic to cells via
Fenton and related redox chemistry [3,7]. Strict regulatory systems
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must be appropriately maintained to ensure a sufficient supply of iron
for essential processes whilst protecting vulnerable neurons from iron-
mediated toxicity.
Whilst the iron storage protein, ferritin, is the dominant iron sink in
glial cells of the SNc, iron in nigral neurons is primarily bound by the
biological polymer, neuromelanin (NM) [8,9]. NM pigments dopami-
nergic neurons of the SNc and noradrenergic neurons in the locus
coeruleus, the two brain regions most susceptible to neuron loss during
the progression of PD [10]. Similar to ferritin, NM also sequesters fer-
rous iron and binds it in a redox-stabilised ferric form, forming iron
oxide clusters which comprise around 10%–20% of total iron in the
substantia nigra [11]. It has been proposed that the antioxidant de-
fences offered by iron-binding molecules such as ferritin and NM may
be impaired by the ageing process, thereby increasing vulnerability
towards age-related neurodegeneration. [3,12]. Moreover, it is possible
that the storage capacity of these iron reservoirs may be particularly
compromised in PD, leading to hazardous levels of redox-active iron
contained within, or in the immediate vicinity of vulnerable neurons
[13–15].
Despite the potential implications for disease-specific iron dysre-
gulation in PD, there has only been limited exploration of interactions
between iron and NM in PD substantia nigra using high-resolution
spectromicroscopy [16]. This is chiefly because non-disruptive, label-
free analysis of brain metals poses significant inherent analytical chal-
lenges, whereas use of stains or chemical fixatives can significantly
influence metal ion distributions and/or concentrations in tissues
[17–19]. Synchrotron-based techniques to study subcellular structure
and chemistry in disease pathology are consequently of current interest
[20], since these methods can be applied without sample ablation or
requirement for additional staining (i.e. they are label-free) [21]. Re-
cent developments in soft x-ray synchrotron techniques represent a
pivotal advancement in this field, allowing inorganic metal distribu-
tions to be visualised with respect to organic, anatomical tissue struc-
ture.
Scanning Transmission X-ray Microscopy (STXM) is one such syn-
chrotron-based, soft x-ray approach, particularly suited to providing
combined imaging and spectral data on biological tissue samples. In
STXM, the energy of the incident beam can be precisely tuned and
stepped over a desired range to generate x-ray absorption spectra over a
targeted absorption edge (e.g. carbon or iron K-edges). The high energy
resolution attainable with STXM (ca. 0.1 eV) promotes sensitivity to-
wards chemical variations in the sample, allowing speciation of en-
dogenous metal ions. Image contrast can also be generated by ex-
ploiting distinct spectral features to create speciation maps, illustrating
not only the distribution of individual elements, but the distribution of
specific molecules and ions (e.g. proteins, Fe2+/Fe3+). This powerful
analytical tool has previously been applied to perform specific mapping
of organic tissue components [21] and to advance understanding of
Alzheimer’s disease aetiology, characterising interactions between
metal ions and the amyloid-beta peptide in both in vitro [22–24] and ex
vivo [25] studies.
The aim of this study was to apply STXM to the characterisation of
iron deposits and their local environment within neuromelanin-con-
taining neurons of Parkinson’s disease SNc. Combined imaging and
spectral data were used to demonstrate the heterogeneous structure and
composition of post-mortem brain tissue samples, whilst also detecting
variations in the oxidation state of neuronal iron.
2. Materials and methods
2.1. Tissue preparation
Frozen unfixed substantia nigra tissue from a confirmed PD case was
obtained from the Canadian Brain Tissue Bank and prepared and ana-
lysed under current ethical approvals 07/MRE08/12 and REGO-2018-
2223.
Substantia nigra tissue was cut into cubes approximately 8mm3 in
volume using a non-metallic knife to prevent metal contamination, and
dehydrated using an ethanol series (40%–100% dry). Following dehy-
dration, tissue cubes were embedded in an aliphatic epoxy resin com-
posed of an equimolar mixture of trimethylolpropane triglycidyl ether
and 4,4′-methylenebis-(2-methylcyclohexylamine), purchased from
Sigma Aldrich (Dorset, UK), and cured at 60 °C overnight.
Prior work demonstrated that ferric iron standards prepared using
the same embedding series as for the substantia nigra tissue show no
evidence of iron reduction when examined using STXM [26]. Thus,
whilst the absolute concentrations of loosely-bound metal ions may be
altered by the resin-embedding process, it is likely that iron oxidation
state is preserved.
For soft x-ray spectromicroscopy (STXM) experiments, semi-thin,
500 nm thick sections of resin embedded substantia nigra tissue were
cut using a Reichert-Jung ultra-cut microtome, operating with a dia-
mond blade (DiATOME Ultra 45°). Sections were mounted on copper
TEM grids for STXM examination. No dyes or contrast agents were
applied.
2.2. Scanning transmission X-ray microscopy
STXM experiments were performed on Diamond Light Source
beamline I08 (Oxfordshire, UK), and the Advanced Light Source
beamline 11.0.2 (Berkeley, CA, USA). Microscopy images were ob-
tained by tuning the incident x-ray beam to a specific energy, raster
scanning the sample across a focussed beam of< 50 nm spot size, and
recording the transmitted X-ray intensity. Exposure times were kept to a
minimum (≤ 10ms per point) to prevent radiation damage.
Speciation maps showing the nanoscale distribution of particular
elements or chemical states were generated by collecting paired images:
a “peak” image at the energy corresponding to a feature of interest (e.g.
the principal Fe3+ L3-edge peak at 709.5 eV), and an “off-peak” image a
few eV below this feature. The off-peak image was then subtracted from
the peak image providing a speciation map devoid of artefacts (from for
example, the embedding resin). Speciation maps were created for fea-
tures at the oxygen K-edge (520−545 eV) and the iron L3-edge
(700−716 eV).
Iron L3-edge x-ray absorption spectra, providing detailed informa-
tion regarding the oxidation state of the measured iron deposits, were
obtained by collecting images of a region of interest at multiple x-ray
energies across the absorption edge. Normalisation of the x-ray ab-
sorption spectra was achieved by converting the raw x-ray absorption
intensity to optical density using background regions that did not
contain any iron material (e.g. areas of the resin that are devoid of
tissue). The “dark count”, i.e. the background noise attributable to the
beamline, was determined by acquiring a single image with no incident
x-ray beam and subtracted from the stack before conversion to optical
density. By performing this form of spectromicroscopy, x-ray absorp-
tion spectra can be generated from each pixel of an image, allowing the
iron oxidation state from highly localised (< 50 nm) regions of interest
to be determined. A three-point average smoothing was applied to all
iron L3-edge x-ray absorption spectra collected.
STXM data processing was performed using the aXis 2000 software
package (http://unicorn.mcmaster.ca/aXis2000.html). Pseudo-co-
loured composite images were created by converting greyscale images
to false colour, before recombining the images as an overlay using
ImageJ.
The data that support the findings in this study will be available in
the Warwick Research Archive Portal (WRAP) repository, https://wrap.
warwick.ac.uk/137342.
3. Results
STXM images, speciation maps and an iron L3-edge x-ray absorption
spectrum from a neuromelanin-containing neuron within an embedded
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section of PD substantia nigra are shown in Fig. 1. An oxygen K-edge
speciation map taken at 532 eV, displaying tissue ultrastructure, is
shown in Fig. 1a. From this map a clear cell border and intracellular
structure can be seen. An off-resonance 530 eV image is shown in
Fig. 1b, in which an intracellular cluster of NM is visible as a region of
high contrast, owing to NM’s higher optical density compared to the
surrounding neuropil at this energy. Iron L3-edge mapping of the
neuron at 709.5 eV (Fig. 1d), showed a cellular iron distribution which
closely matches that of NM (Fig. 1b and e), suggesting that NM is
loaded with iron.
To establish the oxidation state of the NM-associated iron, x-ray
spectromicroscopy was performed over the iron L3-edge. At the L3-edge,
ferric (Fe3+) materials display a principal absorption peak at 709.5 eV
and a further low intensity peak at 708 eV (for reference spectrum see
Fig. 1f; orange spectrum). In contrast, pure ferrous (Fe2+) materials
display a single peak at 708 eV (see Fig. 1f; green spectrum). Therefore,
increases in the Fe2+ content of an originally ferric material result in an
increased peak intensity at 708 eV with respect to the feature at
709.5 eV. The iron L3-edge x-ray absorption spectrum from the NM-
associated iron (Fig. 1f; blue spectrum) strongly resembled the ferrous
standard, demonstrating this iron to be predominantly Fe2+.
A STXM image and iron L3-edge x-ray absorption spectra from a
further NM cluster located within the same tissue section are shown in
Fig. 2. In the 709.5 eV image (Fig. 2a), a large> 15 μm diameter
cluster of NM is evident, within which individual NM granules
(< 600 nm diameter) can be resolved.
Iron L3-edge x-ray absorption spectra from five individual NM
granules are shown in Fig. 2b. Even within nanoscale regions, a clear
variation in iron oxidation state can be seen in the different NM gran-
ules. The spectra from the areas labelled B1–B2 are characteristic of an
Fe3+ phase. In contrast, spectra B3→B5 displayed increased Fe2+ fea-
tures, as evidenced by the enhancement of the feature at 708 eV in
relation to the principal Fe3+ peak at 709.5 eV, and are plotted in as-
cending order with regards to their Fe2+ content. These results again
show the presence of chemically reduced iron associated with NM in PD
substantia nigra, and suggest that the degree of reduction can vary
between adjacent NM granules.
Fig. 1. X-ray speciation maps, images, and an iron L3-edge x-ray absorption spectrum from a neuromelanin-containing neuron within a PD substantia nigra tissue
section. (a) Oxygen K-edge tissue map. (b) Off-peak 530 eV image, showing NM granules as areas of strong contrast. (c) Composite image displaying tissue (cyan) and
NM (red) content. (d) Iron L3-edge speciation map and (e) composite image displaying iron (blue) and NM (red), from the area highlighted in (b). (f) Iron L3-edge
spectrum (blue) from the NM area shown in (d). Ferric (Fe3+; orange) and ferrous (Fe2+; green) standard spectra are also provided for reference. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web version of this article).
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4. Discussion
Despite the association between elevated iron levels and PD having
been recognised for nearly a century, the mechanisms linking iron
dysregulation and neurotoxicity are not yet fully understood, and it
remains unclear as to why dopaminergic neurons in the SNc are so
heavily affected by neurodegeneration, whilst other iron-rich nuclei are
spared [13].
This work demonstrates that STXM is a powerful tool for analysing
NM clusters and associated iron distributions within neuromelanin-
containing neurons, without requirement for chemically disruptive
staining. The ability to characterise metal ion distributions in context
with the surrounding anatomical tissue structure without labelling of-
fers unique potential to investigate the native chemistry of tissue
samples in situ. This is particularly pertinent to analysis of vulnerable
neuromelanin-containing neurons in the PD substantia nigra, where
elevated iron levels have consistently been reported [2,27,28].
The positive identification of NM was informed by related recently-
published work confirming the utility of STXM for label-free imaging of
NM [21]. Spectral features shared by NM clusters and synthetic NM
were used to create speciation maps demonstrating equivalent dis-
tributional information to that obtained from silver nitrate staining in
consecutive tissue sections [21]. Because STXM signal relies on energy-
dependent x-ray transmission through the resin-embedded tissue sec-
tions, and on analyte concentration at a specific absorption edge, the
prior NM labelling work was optimised at the lower-energy carbon K-
edge in thinner (200 nm) sections. In the present study, thicker 500 nm
sections were used to maximise iron signal for the chemical speciation
of NM-associated iron. In these 500 nm sections we confirmed that the
off-resonance signal near the oxygen edge (530 eV, Fig. 1) evidences
sufficient contrast from the NM clusters that the NM distribution and
chemical speciation of NM-associated iron could be studied in a single
section, as illustrated here. NM granules were distinguished by their
characteristic granular morphology and increased optical density re-
lative to surrounding cellular ultrastructure at the oxygen K-edge. We
note that both the morphology and surrounding cellular context of large
intracellular neuromelanin clusters were entirely consistent with large
intracellular neuromelanin clusters observed previously using silver
nitrate labelling, or optimised carbon K-edge STXM mapping [21].
We show that x-ray spectromicroscopy using STXM provides suffi-
ciently high spatial resolution and chemical sensitivity to allow acqui-
sition of x-ray absorption spectra from individual NM granules. Dense
clusters of NM approximately 300−500 nm in diameter are shown to
be loaded with iron, consistent with the well-documented high affinity
of NM for metal ions [29–31]. Nanoscale variations in iron oxidation
state were observed amongst NM granules, highlighting the need for
nanoscale spatial resolution when examining the biochemistry of tissue
samples, whilst also drawing attention to the remarkable specificity of
STXM for speciation analysis.
Destructive microprobe techniques such as laser ablation in-
ductively coupled plasma mass spectrometry (LA-ICP-MS) have been
utilised effectively for the purpose of quantifying metal concentrations
in targeted regions of tissue [32,33]. Whilst such techniques are ideally
suited to quantification and can certainly achieve exceptional chemical
sensitivity, the capacity to distinguish different metal oxidation states
or to measure regions on the nanoscale is lacking [34]. STXM can
elucidate metal speciation on the nanoscale, whilst also preserving the
sample for complementary analysis. The ability to acquire large vo-
lumes of data from small volumes of sample is particularly important to
post-mortem tissue studies, where sample supply is necessarily con-
strained [35].
With iron typically stored in a ferric (Fe3+) state within NM gran-
ules, the presence of chemically reduced iron is certainly intriguing
with regards to the hypothesis that the antioxidant metal-binding
Fig. 2. (a) An iron L3-edge x-ray image and (b) x-ray absorption spectra from NM granules in a PD substantia nigra tissue section, demonstrating nanoscale variation
in iron oxidation state. X-ray spectra in (b) correspond to the areas highlighted in (a). The dotted-dashed line at 708 eV in (b) indicates the peak absorption energy for
Fe2+.
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function of NM may be compromised by ageing, or even specifically in
Parkinson’s disease [13–15]. NM-bound iron clusters measured with
identical x-ray doses showed both ferric and ferrous-rich forms of iron.
We have previously shown that such effects are not caused by artefacts
such as x-ray beam reduction [25]; therefore, the localised variation in
iron oxidation state supports the possibility of redox cycling between
ferric (Fe3+) and ferrous (Fe2+) ions, potentially accompanied by
generation of toxic species such as free radicals.
Redox cycling of metal ions (including iron, manganese and copper)
may be instrumental in exacerbating oxidative stress in the brain, a
mechanism which is receiving growing attention concerning its asso-
ciation with neurodegeneration and ageing in general [4,36–38]. The
results shown here provide proof-of-concept using tissue from a single
PD case. The highly localised variations in iron oxidation state within
neuromelanin-containing neurons clearly warrants further investiga-
tion, to incorporate additional PD casesand neurologically healthy
controls.
In summary, we demonstrate that soft x-ray spectromicroscopy
using STXM offers a level of information which would normally de-
mand extensive application of multiple complementary techniques,
each requiring independent sample preparation. The detection of sig-
nals for both organic and inorganic components, combined with the
high spatial resolution, specificity, and sensitivity for trace metal de-
tection, makes STXM a powerful method for in-depth studies of dis-
rupted biochemistry in the PD brain.
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